Linda M. Liau
University of California, Los Angeles(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cancer, Lipids, and Metabolism, CAR-T cell therapy research
Most-Cited Works
- → Cancer-associated IDH1 mutations produce 2-hydroxyglutarate(2009)4,077 cited
- → Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors(2005)1,445 cited
- → Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma(2019)1,356 cited
- → Intertumoral Heterogeneity within Medulloblastoma Subgroups(2017)1,230 cited
- → The whole-genome landscape of medulloblastoma subtypes(2017)1,164 cited
- → Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma(2007)1,081 cited
- → High-throughput oncogene mutation profiling in human cancer(2007)995 cited
- → Gene Expression Profiling of Gliomas Strongly Predicts Survival(2004)737 cited
- → Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target(2006)670 cited